Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

Jon Bjoern; Rikke Lyngaa; Rikke Andersen; Lisbet Rosenkrantz Hölmich; Sine Reker Hadrup; Marco Donia; Inge Marie Svane

doi:10.18632/oncotarget.26359

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

Jon Bjoern, Rikke Lyngaa, Rikke Andersen, Lisbet Rosenkrantz Hölmich, Sine Reker Hadrup, Marco Donia, Inge Marie Svane

Abstract

[This corrects the article DOI: 10.18632/oncotarget.16003.].

Original language	English
Publication date	9 Nov 2018
Edition	88
Volume	9
DOIs	https://doi.org/10.18632/oncotarget.26359
Publication status	Published - 9 Nov 2018

Series	Oncotarget
ISSN	1949-2553

Access to Document

10.18632/oncotarget.26359

Cite this

@misc{d9436bb83c084034af8668ff7c60ee7c,

title = "Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma",

abstract = "[This corrects the article DOI: 10.18632/oncotarget.16003.].",

author = "Jon Bjoern and Rikke Lyngaa and Rikke Andersen and H{\"o}lmich, {Lisbet Rosenkrantz} and Hadrup, {Sine Reker} and Marco Donia and Svane, {Inge Marie}",

year = "2018",

month = nov,

day = "9",

doi = "10.18632/oncotarget.26359",

language = "English",

volume = "9",

series = "Oncotarget",

publisher = "Impact Journals LLC",

edition = "88",

type = "Other",

}

TY - GEN

T1 - Correction

T2 - Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

AU - Bjoern, Jon

AU - Lyngaa, Rikke

AU - Andersen, Rikke

AU - Hölmich, Lisbet Rosenkrantz

AU - Hadrup, Sine Reker

AU - Donia, Marco

AU - Svane, Inge Marie

PY - 2018/11/9

Y1 - 2018/11/9

N2 - [This corrects the article DOI: 10.18632/oncotarget.16003.].

AB - [This corrects the article DOI: 10.18632/oncotarget.16003.].

U2 - 10.18632/oncotarget.26359

DO - 10.18632/oncotarget.26359

M3 - Other contribution

C2 - 30533201

VL - 9

T3 - Oncotarget

ER -

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

Abstract

Access to Document

Fingerprint

Cite this